Status:
COMPLETED
Function Magnetic Resonance Imaging to Assess Two Therapeutic Strategies in Multiple Sclerosis (NeuroRehEM).
Lead Sponsor:
Universitat Jaume I
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
19-60 years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) is an autoimmune disease that causes cognitive and motor disabilities and contributes to decrease patients life quality. Previous results described that there are some MS patie...
Eligibility Criteria
Inclusion
- Multiple Sclerosis Diagnosis.
Exclusion
- Other neurological pathologies comorbidity.
- Magnetic resonance imaging incompatibilities.
- Motor impairment degree that impede the task performance.
Key Trial Info
Start Date :
May 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT05270239
Start Date
May 27 2022
End Date
July 31 2023
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitat Jaume I (ImagoBrain Research Group)
Castellon, Castellón, Spain, 12006